BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34962740)

  • 1. [Erdheim-Chester disease: a rare histiocytosis with outstanding response to cobimetinib.].
    Sosa GA; Dogliani P; Guidi AE; Marangoni MA; Lavarda M; Fainstein-Day P
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):398-401. PubMed ID: 34962740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
    Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
    J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoalphalipoproteinemia and BRAF
    Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
    Qiao J; Ma R; Peng X; He W
    World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis.
    Tsai JW; Tsou JH; Hung LY; Wu HB; Chang KC
    J Am Acad Dermatol; 2010 Aug; 63(2):284-91. PubMed ID: 20633799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
    Kobic A; Shah KK; Schmitt AR; Goyal G; Go RS; Guo R; Rech KL; Sartori-Valinotti JC;
    Br J Dermatol; 2020 Feb; 182(2):405-409. PubMed ID: 31120137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Ischemic Stroke and Erdheim-Chester Disease: A Case Report and Review of Literature.
    Fargeot G; Stefanizzi S; Depuydt S; Klapczynski F; Ameri A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e153-e155. PubMed ID: 28623120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
    Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
    Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.
    Cohen Aubart F; Emile JF; Maksud P; Galanaud D; Cluzel P; Benameur N; Aumaitre O; Amoura Z; Haroche J
    Br J Haematol; 2018 Jan; 180(1):150-153. PubMed ID: 27711968
    [No Abstract]   [Full Text] [Related]  

  • 13. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib.
    Riancho JA; Hernández JL; González-Vela C; López-Sundh AE; González-Lopez MA; Gomez de la Fuente F; Quirce R; Diamond EL
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement].
    Berthe P; Rouzic N; Daelman L; Jacobzone C; Espitia A; Cohen-Aubart F; Haroche J; Émile JF; Lorleac'h A
    Rev Med Interne; 2020 Jun; 41(6):413-417. PubMed ID: 32113636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
    Mazor RD; Manevich-Mazor M; Kesler A; Aizenstein O; Eshed I; Jaffe R; Pessach Y; Goldberg I; Sprecher E; Yaish I; Gural A; Ganzel C; Shoenfeld Y
    BMC Med; 2014 Dec; 12():221. PubMed ID: 25434739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
    Kim S; Lee M; Shin HJ; Lee J; Suh YL
    Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.
    Portegys J; Heidemeier A; Rosenwald A; Gernert M; Fröhlich M; Hueper S; Strunz PP; Rasche L; Schmalzing M
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36693681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.